Cryptocurrencies
Should Biogen Investors Be Worried About Its Alzheimer’s Drug?
A Medicare policy decision might hurt sales of this biotech giant’s Alzheimer’s drug. Alzheimer’s is a cruel disease with no cure. As this brain condition progresses, patients experience greater memory loss and other cognitive difficulties. In Read more…